-
Efficacy and Safety of Acupuncture Combined with Conventional Drug Therapy for the Treatment of Cancer-Induced Bone Pain: A Network Meta-Analysis of Randomized Controlled Trials
16 Dec 2025 11:48 GMT
… and strong opioid medications.21 The experimental … analyses by excluding trials exhibiting substantial overall … trial of K1 acupoint acustimulation to prevent cisplatin-induced or oxaliplatin … three-step analgesic drug therapy for treatment of cancer pain …
-
<![CDATA[Illuminating the Sequence of Third-Line Therapies in Metastatic CRC]]>
18 Dec 2025 05:23 GMT
… of Gastrointestinal Medical Oncology, Division of Cancer Medicine at … key findings from several trials to illustrate how … treatment she experienced grade 2 peripheral neuropathy which stabilized with oxaliplatin … the phase 3 SUNLIGHT trial [NCT04737187].2 This …
-
<![CDATA[MATTERHORN Results Yield Promise in Resectable Gastric/GEJ Cancer]]>
16 Dec 2025 21:43 GMT
… for Medical Oncology (ESMO) Congress 2025.1 This trial looked … fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) as treatment for patients … an anti-PD-L1 drug. Instead of just selecting … and observe, as diligent doctors.
Mehta: Do you anticipate …
-
<![CDATA[Pelareorep Exhibits Activity in Second-Line KRAS-Mutated Metastatic CRC]]>
16 Dec 2025 21:43 GMT
… phase 1 REO 022 trial (NCT01274624) evaluating … MS, professor of Medicine, Division of Medical Oncology, and … metastases; prior treatment with an oxaliplatin-based chemotherapy regimen … of Oncolytics Biotech, concluded.1
Oncolytics Biotech® announces promising …
-
Transcatheter Arterial Chemoembolization May Be Selectively Indicated as Postoperative Adjuvant Therapy for Hepatocellular Carcinoma Patients with Microvascular Invasion
18 Dec 2025 00:28 GMT
… to existing postoperative adjuvant treatment strategies. Consequently, precisely … 10–50 mg) and oxaliplatin (25–100 mg). … , or molecular targeted drug therapy, as appropriate.34 … ; Guangxi Medical University Cancer Hospital Outstanding Doctoral Support Project …
-
KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Significantly Improved Event-Free Survival, Overall Survival and Pathologic Complete Response Rates for Cisplatin-Eligible Patients with MIBC When Given Before and After Surgery
17 Dec 2025 13:34 GMT
… including infection. Institute medical management promptly, including … CAPOX (capecitabine plus oxaliplatin) or FP ( … clinical trial participation, screening and treatment, we … SURGERY CLINICAL TRIALS BIOTECHNOLOGY HEALTH PHARMACEUTICAL GENERAL HEALTH SCIENCE …
-
<![CDATA[Top 5 Most-Read Conference Coverage of 2025]]>
17 Dec 2025 00:01 GMT
… phase 3 POLARGO trial. The trial evaluated the efficacy … with rixutimab, gemcitabine, and oxaliplatin for patients who were … Nonadherence to Chronic Oral Medication
Improving adherence to chronic … Trials at ACC.25 Signal Shift in Chronic Disease Treatment …
-
Prevention and Detection of Early-Onset Colorectal Cancer
16 Dec 2025 16:57 GMT
… nonsteroidal inflammatory drugs (NSAIDs), including medications such as … time from a trial of 7, … fluorouracil, and oxaliplatin); CAPEOX (capecitabine and oxaliplatin); bevacizumab; FOLFIRI … provide additional treatment options.13 Medications recommended by …
-
Expression and Significance of PI3K p85α and p53 Protein in Colorectal Cancer Tissues
15 Dec 2025 10:47 GMT
… from Zhongshan Golden Bridge Biotechnology (China).
Immunohistochemical … collected from two independent medical centers, the sample … cancer patients treated with oxaliplatin-based adjuvant chemotherapy. … for targeted therapeutic treatment in human cancer. …
-
Targeting ALKBH5 Halts Colorectal Cancer Stemness, Resistance
13 Dec 2025 14:15 GMT
… self-renewal capacities and drug resistance mechanisms of CSCs. … such as 5-fluorouracil and oxaliplatin. Such observations underscore ALKBH5 … researchcancer stemness and chemoresistancecancer treatment relapse preventionepitranscriptomic modifications in …